Area of research
Pathology and Forensic Medicine · Molecular Biology
Research interest
Research focused on Lung cancer and Cancer research, with related work in Cell cycle, Cell growth, Carcinogenesis. Notable publications include 'Correlation between patients' age and cancer immunotherapy efficacy', 'LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside', and 'Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease'.
Ofatumumab treatment in patients with neuromyelitis optica spectrum disorder: a retrospective multicenter cohort study
Lactylation-Related Gene CALM1 Promotes Aortic Dissection via Immune Microenvironment Remodeling: Insights from Bioinformatics and Clinical Evidence
Batoclimab vs Placebo for Generalized Myasthenia Gravis
Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter study
Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer
Shedding light on macrophage immunotherapy in lung cancer
LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside
Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma
Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer
The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response
Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis
Integrative Analysis of Multi-Omics Data-Identified Key Genes With KLRC3 as the Core in a Gene Regulatory Network Related to Immune Phenotypes in Lung Adenocarcinoma
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
SNX20 Expression Correlates with Immune Cell Infiltration and Can Predict Prognosis in Lung Adenocarcinoma
PRDX5 as a novel binding partner in Nrf2-mediated NSCLC progression under oxidative stress
PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway
ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC
Relevance of STK11 Mutations Regarding Immune Cell Infiltration, Drug Sensitivity, and Cellular Processes in Lung Adenocarcinoma
The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma
Correlation between patients' age and cancer immunotherapy efficacy.
Efficacy and safety of CTLA-4 inhibitors combined with PD-1 inhibitors or chemotherapy in patients with advanced melanoma
PIDD interaction with KEAP1 as a new mutation-independent mechanism to promote NRF2 stabilization and chemoresistance in NSCLC
Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer
Anterior fissureless uniport vs. posterior intra-fissure triple-port thoracoscopic right upper lobectomy: a propensity-matched study
Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer
Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis
TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway
Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinoma
Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation
The expression levels and prognostic value of high temperature required A2 (HtrA2) in NSCLC